Previous close | 2.8100 |
Open | 2.8100 |
Bid | 2.1000 |
Ask | 2.6100 |
Strike | 110.00 |
Expiry date | 2025-12-19 |
Day's range | 2.8100 - 2.8100 |
Contract range | N/A |
Volume | |
Open interest | 21 |
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.